» Articles » PMID: 32542445

Identification of Areas of Grading Difficulties in Prostate Cancer and Comparison with Artificial Intelligence Assisted Grading

Abstract

The International Society of Urological Pathology (ISUP) hosts a reference image database supervised by experts with the purpose of establishing an international standard in prostate cancer grading. Here, we aimed to identify areas of grading difficulties and compare the results with those obtained from an artificial intelligence system trained in grading. In a series of 87 needle biopsies of cancers selected to include problematic cases, experts failed to reach a 2/3 consensus in 41.4% (36/87). Among consensus and non-consensus cases, the weighted kappa was 0.77 (range 0.68-0.84) and 0.50 (range 0.40-0.57), respectively. Among the non-consensus cases, four main causes of disagreement were identified: the distinction between Gleason score 3 + 3 with tangential cutting artifacts vs. Gleason score 3 + 4 with poorly formed or fused glands (13 cases), Gleason score 3 + 4 vs. 4 + 3 (7 cases), Gleason score 4 + 3 vs. 4 + 4 (8 cases) and the identification of a small component of Gleason pattern 5 (6 cases). The AI system obtained a weighted kappa value of 0.53 among the non-consensus cases, placing it as the observer with the sixth best reproducibility out of a total of 24. AI may serve as a decision support and decrease inter-observer variability by its ability to make consistent decisions. The grading of these cancer patterns that best predicts outcome and guides treatment warrants further clinical and genetic studies. Results of such investigations should be used to improve calibration of AI systems.

Citing Articles

Automating Prostate Cancer Grading: A Novel Deep Learning Framework for Automatic Prostate Cancer Grade Assessment using Classification and Segmentation.

Kabir S, Sarmun R, Al Saady R, Vranic S, Murugappan M, Chowdhury M J Imaging Inform Med. 2025; .

PMID: 39913023 DOI: 10.1007/s10278-025-01429-2.


Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers.

Logan J, Martini C, Sorvina A, Johnson I, Brooks R, Caruso M Sci Data. 2024; 11(1):852.

PMID: 39117701 PMC: 11310308. DOI: 10.1038/s41597-024-03696-0.


Harnessing artificial intelligence for prostate cancer management.

Zhu L, Pan J, Mou W, Deng L, Zhu Y, Wang Y Cell Rep Med. 2024; 5(4):101506.

PMID: 38593808 PMC: 11031422. DOI: 10.1016/j.xcrm.2024.101506.


Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.

Hietikko R, Mirtti T, Kilpelainen T, Tolonen T, Raisanen-Sokolowski A, Nordling S World J Urol. 2024; 42(1):217.

PMID: 38581590 PMC: 10998811. DOI: 10.1007/s00345-024-04898-2.


Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.

Eminaga O, Abbas M, Kunder C, Tolkach Y, Han R, Brooks J Sci Rep. 2024; 14(1):5284.

PMID: 38438436 PMC: 10912767. DOI: 10.1038/s41598-024-55228-w.


References
1.
Egevad L, Delahunt B, Berney D, Bostwick D, Cheville J, Comperat E . Utility of Pathology Imagebase for standardisation of prostate cancer grading. Histopathology. 2018; 73(1):8-18. PMC: 7838555. DOI: 10.1111/his.13471. View

2.
Zhou M, Li J, Cheng L, Egevad L, Deng F, Kunju L . Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol. 2015; 39(10):1331-9. DOI: 10.1097/PAS.0000000000000457. View

3.
Melia J, Moseley R, Ball R, Griffiths D, Grigor K, Harnden P . A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology. 2006; 48(6):644-54. DOI: 10.1111/j.1365-2559.2006.02393.x. View

4.
Obermeyer Z, Emanuel E . Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016; 375(13):1216-9. PMC: 5070532. DOI: 10.1056/NEJMp1606181. View

5.
Goldenberg S, Nir G, Salcudean S . A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019; 16(7):391-403. DOI: 10.1038/s41585-019-0193-3. View